Skip to main content

Sexual Dysfunction

5
Pipeline Programs
6
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
4
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Otsuka
OtsukaJapan - Tokushima
1 program
1
Abilify MaintenaPhase 41 trial
Active Trials
NCT02472652Terminated2Est. Mar 2017
Bayer
BayerLEVERKUSEN, Germany
1 program
1
LevitraPhase 41 trial
Active Trials
NCT00377793Completed352Est. Aug 2007
ViiV Healthcare
ViiV HealthcareNC - Durham
1 program
1
RopinirolePhase 4
Pfizer
PfizerNEW YORK, NY
1 program
1
sildenafilPhase 41 trial
Active Trials
NCT00375297Completed100Est. Jun 2005
Alliance Pharmaceuticals
1 program
1
Maca RootPhase 31 trial
Active Trials
NCT00575328Terminated8Est. Apr 2010
Joylux
JoyluxWA - Seattle
1 program
vSculptN/A1 trial
Active Trials
NCT02856490Completed6Est. Dec 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OtsukaAbilify Maintena
BayerLevitra
Pfizersildenafil
Alliance PharmaceuticalsMaca Root
JoyluxvSculpt

Clinical Trials (5)

Total enrollment: 468 patients across 5 trials

NCT02472652OtsukaAbilify Maintena

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Start: Jun 2015Est. completion: Mar 20172 patients
Phase 4Terminated
NCT00377793BayerLevitra

Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II

Start: Jul 2006Est. completion: Aug 2007352 patients
Phase 4Completed
NCT00375297Pfizersildenafil

Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women

Start: Jan 2001Est. completion: Jun 2005100 patients
Phase 4Completed
NCT00575328Alliance PharmaceuticalsMaca Root

Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females

Start: Feb 2008Est. completion: Apr 20108 patients
Phase 3Terminated
NCT02856490JoyluxvSculpt

A Study to Measure the Degree and Effectiveness of the Various vSculpt Operating Modes

Start: Jul 2016Est. completion: Dec 20166 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.